TRENTON, N.J.—U.S. regulators on Friday approved a new type of cholesterol-lowering drug aimed at millions of people who can’t tolerate—or don’t get enough help from—widely used statin pills like Lipitor and Crestor.
The Food and Drug Administration approved Esperion Therapeutics Inc.’s Nexletol for people genetically predisposed to have sky-high cholesterol and people who have heart disease and need to further lower their bad cholesterol. The daily pill is to be taken in conjunction with a healthy diet and the highest statin dose patients can handle, the FDA said.
